Arcosa Valuation
Is ACA * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ACA * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ACA * (MX$1404) is trading above our estimate of fair value (MX$1283.46)
Significantly Below Fair Value: ACA * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ACA *?
Other financial metrics that can be useful for relative valuation.
What is ACA *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$4.27b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2x |
Enterprise Value/EBITDA | 13.8x |
PEG Ratio | 1.4x |
Price to Earnings Ratio vs Peers
How does ACA *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 31.2x | ||
IDEAL B-1 Impulsora del Desarrollo y el Empleo en América Latina. de | 15x | n/a | Mex$111.5b |
ARISTOS A Consorcio Aristos. de | 87.7x | n/a | Mex$6.9b |
GMD * Grupo Mexicano de Desarrollo | 7.1x | n/a | Mex$2.2b |
LAMOSA * Grupo Lamosa. de | 14.8x | n/a | Mex$43.4b |
ACA * Arcosa | 30.2x | 21.0% | Mex$4.3b |
Price-To-Earnings vs Peers: ACA * is expensive based on its Price-To-Earnings Ratio (30x) compared to the peer average (12.3x).
Price to Earnings Ratio vs Industry
How does ACA *'s PE Ratio compare vs other companies in the Global Construction Industry?
Price-To-Earnings vs Industry: ACA * is expensive based on its Price-To-Earnings Ratio (30x) compared to the Global Construction industry average (15.4x).
Price to Earnings Ratio vs Fair Ratio
What is ACA *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 30x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ACA *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.